← Back to Clinical Trials
Recruiting NCT03588481

NCT03588481 IRIS- DESyne X2 in the IRIS-DES Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03588481
Status Recruiting
Phase —
Sponsor Seung-Jung Park
Condition Coronary Stenosis
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2018-11-28
Primary Completion 2026-12-31

Trial Parameters

Condition Coronary Stenosis
Sponsor Seung-Jung Park
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 19 Years
Max Age N/A
Start Date 2018-11-28
Completion 2026-12-31
Interventions
DESyne X2

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.

Eligibility Criteria

Inclusion Criteria: * Age 19 and more * Intervention with DeSyne X2 drug-eluting coronary stent * Agreed with written informed consent form Exclusion Criteria: * Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time * Life expectancy of 1year and under * Cardiac shock

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE CORONARY STENOSIS TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology